Engineered Bacterial Outer Membrane Vesicles Hitchhiking on Neutrophils for Antibody Drug Delivery to Enhance Postoperative Immune Checkpoint Therapy
Authors:
Open Access
- 27 April 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 12 (27) , e2505000
Abstract
In clinical practice, surgical removal of tumors often leaves behind small tumors and circulating tumor cells, increasing the risk of metastasis and recurrence, which seriously affects treatment outcomes. Immunotherapy activates the immune system to monitor and inhibit tumor metastasis and recurrence long‐term. However, inflammatory microenvironments at surgical sites lead to immunosuppressive tumor‐associated macrophages (TAMs), causing immune evasion. Additionally, tumor cells overexpress the immune checkpoint CD47, further weakening the phagocytic and cytotoxic functions of macrophages. Here, the bacterial outer membrane vesicles (OMV) hitchhiking on neutrophils are utilized to precisely deliver immune checkpoint blockade antibodies to the tumor resection site. Escherichia coli is reprogrammed to express CD47 antibody and used to extract CD47 antibody‐containing OMV, followed by insertion of Ce6 photosensitizer into the membrane (OC47‐Ce6). Purified autologous neutrophils phagocytose and carry OC47‐Ce6 for precise targeting to the postoperative tumor resection site, mediating tumor cell killing, aCD47 release, and tumor‐associated antigen presentation by light. In vitro and in vivo experiments demonstrate that OC47‐Ce6 enhances TAM phagocytic function through TAM polarization and CD47 blockade. This approach effectively activates T‐cell anti‐tumor immune responses and significantly reduces the risk of postoperative tumor recurrence and metastasis.Keywords
Funding Information
- National Natural Science Foundation of China (62375093)
- National Natural Science Foundation of China (62305121)
- National Natural Science Foundation of China (82373104)
This publication has 30 references indexed in Scilit:
- Nanoplatforms derived from iron dextran combined with ascorbic acid for enhanced photothermal-chemodynamic therapy of tumorsChemical Engineering Journal, 2024
- Unveiling the promise: Exosomes as game‐changers in anti‐infective therapyExploration, 2024
- Beyond Extracellular Vesicles: Hybrid Membrane Nanovesicles as Emerging Advanced Tools for Biomedical ApplicationsAdvanced Science, 2023
- Bacteria‐Derived Outer‐Membrane Vesicles Hitchhike Neutrophils to Enhance Ischemic Stroke TherapyAdvanced Materials, 2023
- Engineered Bacterial Outer Membrane Vesicles as Controllable Two‐Way Adaptors to Activate Macrophage Phagocytosis for Improved Tumor ImmunotherapyAdvanced Materials, 2022
- Progress of engineered bacteria for tumor therapyAdvanced Drug Delivery Reviews, 2022
- Antibody Engineered Platelets Attracted by Bacteria‐Induced Tumor‐Specific Blood Coagulation for Checkpoint Inhibitor ImmunotherapyAdvanced Functional Materials, 2021
- Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer TherapyAdvanced Materials, 2020
- Engineered Bacterial Bioreactor for Tumor Therapy via Fenton‐Like Reaction with Localized H2O2 GenerationAdvanced Materials, 2019
- SIRPα–CD47 Immune Checkpoint Blockade in Anticancer TherapyTrends in Immunology, 2018